Status:
UNKNOWN
Childhood TB Sequel
Lead Sponsor:
London School of Hygiene and Tropical Medicine
Collaborating Sponsors:
European and Developing Countries Clinical Trials Partnership (EDCTP)
Conditions:
Tuberculosis, Pulmonary
Eligibility:
All Genders
Up to 19 years
Brief Summary
This study aims to describe the long-term adverse outcomes associated with PTB in children, to describe the evolution of these sequelae, and to determine the epidemiological risk factors associated wi...
Detailed Description
In the past, treatment success in TB has been defined as the eradication of active infection while preventing resistance. However, this definition of TB treatment outcome, which is based on clinical i...
Eligibility Criteria
Inclusion
- Aged 19 years and below
- Reside in the Greater Banjul Area
- Were diagnosed with either confirmed or unconfirmed PTB
- Have completed treatment with an outcome of 'cured' or 'treatment completed' according to the Gambia NLTP guideline
- Parent/caregiver willing to provide written informed consent, as well as assent for the children
Exclusion
- Relocate from the study area during the follow-up period. If they are reachable by telephone, they will be excluded from study visits in the clinic but will continue to be followed up via telephone calls
- Develop tuberculosis disease during the follow-up period
Key Trial Info
Start Date :
March 29 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05325125
Start Date
March 29 2022
End Date
June 1 2024
Last Update
September 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MRCG at LSHTM
Fajara, The Gambia